Yona Barak
Intra-Cytoplasmic Sperm Injection (ICSI) in humans was first introduced in 1992. ICSI enabled to achieve fertilization,
embryo development and pregnancies. It seemed that the importance of routine parameters of sperm morphology
decreased in the field of assisted reproduction. However, one of the main concerns in ICSI is the aspiration of good-quality
spermatozoa for microinjection into an oocyte.
